Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database.

OBJECTIVES The aim of this study was to understand the causes of implantable cardioverter defibrillator (ICD) failure and complications so that adverse events, including unnecessary death, can be prevented. BACKGROUND Sudden death may occur if an ICD fails to treat life-threatening ventricular arrhythmias. METHODS The United States Food and Drug Administration Manufacturer and User Facility Device Experience Database was searched for ICD devices and the search term "death." The search yielded 212 death events involving 100 ICD pulse generator and lead models from five manufacturers. These death events were associated with (A) ICD devices for which pulse generator interrogation data and/or the results of the manufacturers analysis of returned devices were available; (B) ICD devices for which neither interrogation data nor the results of the manufacturer's analysis were reported; and (C) normally functioning ICDs that had been deactivated. RESULTS (A) A total of 103 (69%) of 150 death events were associated with defective pulse generators or high-voltage leads. Most (34/42 [81%]) apparently sudden or arrhythmic death events were associated with high-voltage lead failure; other deaths were related to pulse generator failure (8/42 [19%]) caused by electronic component defects. (B) A total of 21 of 51 death events were related to a manufacturer's recall; all deaths were arrhythmic but without allegation of device failure. (C) Eleven death events occurred in patients whose pulse generators were found to be off or deactivated; these devices appeared to have been deactivated accidentally or by exposure to magnetic fields, or they were not reactivated after elective surgery. CONCLUSIONS ICD device failure and unintended pulse generator deactivation have resulted in unnecessary deaths. Although these deaths may be infrequent, improved devices and follow-up techniques are needed. The magnet deactivation feature probably is unsafe, and health professionals and patients should be cautioned.

[1]  M. Sweeney.  Exploding Implantable Cardioverter Defibrillator , 2001, Cardiovascular Electrophysiology.

[2]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[3]  B. Lüderitz,et al.  Incidence of ICD Lead Related Complications During Long‐Term Follow‐Up: Comparison of Epicardial and Endocardial Electrode Systems , 1995, Pacing and clinical electrophysiology : PACE.

[4]  S. Hammill,et al.  Unintentional deactivation of implantable cardioverter-defibrillators in health care settings. , 2002, Mayo Clinic proceedings.

[5]  V. Parsonnet,et al.  Unexpected ICD Pulse Generator Failure Due to Electronic Circuit Damage Caused by Electrical Overstress , 2001, Pacing and clinical electrophysiology : PACE.

[6]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[7]  Tim Vaughn,et al.  Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. , 2003, Journal of the American College of Cardiology.

[8]  Victor Parsonnet,et al.  Long‐Term Structural Failure of Coaxial Polyurethane Implantable Cardioverter Defibrillator Leads , 2002, Pacing and clinical electrophysiology : PACE.

[9]  K. Lee,et al.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. , 2000, The New England journal of medicine.

[10]  D. Zenker,et al.  Subthreshold Test Pulses Versus Low Energy Shock Delivery to Estimate High Energy Lead Impedance in Implanted Cardioverter Defibrillator Patients , 2003, Pacing and clinical electrophysiology : PACE.

[11]  B. Wilkoff,et al.  Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. , 2001, American heart journal.

[12]  V Parsonnet,et al.  Feasibility and Initial Results of an Internet‐Based Pacemaker and ICD Pulse Generator and Lead Registry , 2001, Pacing and clinical electrophysiology : PACE.

[13]  C. Schuger,et al.  Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. , 1999, Journal of the American College of Cardiology.

[14]  Douglas S Lee,et al.  Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[15]  M. Hull,et al.  Sudden Death in Recipients of Transvenous Implantable Cardioverter Defibrillator Systems: , 1999, Journal of cardiovascular electrophysiology.

[16]  Magney Je.  Transvenous defibrillator lead damage. , 1995 .

[17]  K. Püschel,et al.  "Natural death" of a patient with a deactivated implantable-cardioverter-defibrillator (ICD)? , 2002, Forensic science international.

[18]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[19]  Uwe Dorwarth,et al.  Transvenous Defibrillation Leads: High Incidence of Failure During Long‐Term Follow‐Up , 2003, Journal of cardiovascular electrophysiology.

[20]  M. Rosenqvist,et al.  Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. , 1998, Circulation.

[21]  J. Ruskin,et al.  Subclavian Crush Syndrome Complicating Transvenous Cardioverter Defibrillator Systems , 1995, Pacing and clinical electrophysiology : PACE.

[22]  D. Mehta,et al.  Late Complications in Patients with Pectoral Defibrillator Implants with Transvenous Defibrillator Lead Systems: High Incidence of Insulation Breakdown , 1998, Pacing and clinical electrophysiology : PACE.

[23]  J. Gummert,et al.  Sensing Lead Insulation Defect Resulting in a Damage of the ICD Pulse Generator Case , 1998, Pacing and clinical electrophysiology : PACE.

[24]  Günter Breithardt,et al.  ICD Leads: , 2003, Pacing and clinical electrophysiology : PACE.

[25]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[26]  D. Delurgio,et al.  Transvenous Cardioverter Defibrillator Lead Malfunction Due to Terminal Connector Damage in Pectoral Implants , 1999, Pacing and clinical electrophysiology : PACE.

[27]  S. Connolly,et al.  Standardized Reporting of ICD Patient Outcome: The Report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9–10, 1993 , 1993, Pacing and clinical electrophysiology : PACE.

[28]  R N Fogoros,et al.  Accidental deactivation of the automatic implantable cardioverter defibrillator. , 1990, American heart journal.

[29]  A. Buchwald,et al.  Early Detection of Lead Fracture by Painless High Voltage Lead Impedance Measurement in a Transvenous ICD Lead System , 2000, Journal of Interventional Cardiac Electrophysiology.